These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23995714)

  • 1. Predictors of stent strut malapposition in calcified vessels using frequency-domain optical coherence tomography.
    Lindsay AC; Paulo M; Kadriye K; Tejeiro R; Alegría-Barrero E; Chan PH; Foin N; Syrseloudis D; Di Mario C
    J Invasive Cardiol; 2013 Sep; 25(9):429-34. PubMed ID: 23995714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing.
    Radu M; Jørgensen E; Kelbæk H; Helqvist S; Skovgaard L; Saunamäki K
    EuroIntervention; 2011 Jul; 7(3):353-61. PubMed ID: 21729838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study.
    Agrawal M; Hakeem A; Ahmed Z; Uretsky BF
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):225-232. PubMed ID: 28805036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.
    Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Dec; 28(8):1887-94. PubMed ID: 22447206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study.
    Giglioli C; Formentini C; Romano SM; Cecchi E; Baldereschi GJ; Landi D; Chiostri M; Prati F; Marchionni N
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):217-230. PubMed ID: 31667661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent malapposition, strut coverage and atherothrombotic prolapse after percutaneous coronary interventions in ST-segment elevation myocardial infarction.
    Leone AM; Rebuzzi AG; Burzotta F; De Maria GL; Gardi A; Basile E; Cialdella P; D'Amario D; Paraggio L; Porto I; Aurigemma C; Niccoli G; Trani C; Crea F
    J Cardiovasc Med (Hagerstown); 2019 Mar; 20(3):122-130. PubMed ID: 30601191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation.
    Hong SJ; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2015 Nov; 56(6):1538-44. PubMed ID: 26446634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thin-cap fibroatheroma and large calcification at the proximal stent edge correlate with a high proportion of uncovered stent struts in the chronic phase.
    Ueda T; Uemura S; Watanabe M; Dote Y; Goryo Y; Sugawara Y; Soeda T; Okayama S; Kawata H; Kawakami R; Okura H; Saito Y
    Coron Artery Dis; 2016 Aug; 27(5):376-84. PubMed ID: 27164267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strut apposition after coronary stent implantation visualised with optical coherence tomography.
    Radu M; Jørgensen E; Kelbaek H; Helqvist S; Skovgaard L; Saunamäki K
    EuroIntervention; 2010 May; 6(1):86-93. PubMed ID: 20542802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study.
    Prati F; Romagnoli E; Burzotta F; Limbruno U; Gatto L; La Manna A; Versaci F; Marco V; Di Vito L; Imola F; Paoletti G; Trani C; Tamburino C; Tavazzi L; Mintz GS
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1297-305. PubMed ID: 26563859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
    Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound.
    Fujino Y; Bezerra HG; Attizzani GF; Wang W; Yamamoto H; Chamié D; Kanaya T; Mehanna E; Tahara S; Nakamura S; Costa MA
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E173-83. PubMed ID: 23359350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between stent malapposition and incomplete neointimal coverage after drug-eluting stent implantation.
    Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y
    J Interv Cardiol; 2012 Jun; 25(3):270-7. PubMed ID: 22372890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular Response to Experimental Stent Malapposition and Under-Expansion.
    O'Brien CC; Lopes AC; Kolandaivelu K; Kunio M; Brown J; Kolachalama VB; Conway C; Bailey L; Markham P; Costa M; Ware J; Edelman ER
    Ann Biomed Eng; 2016 Jul; 44(7):2251-60. PubMed ID: 26732391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study.
    Kim SJ; Lee H; Cho JM; Park CB; Kim W; Kato K; Yonetsu T; Kim CJ; Jang IK
    Coron Artery Dis; 2013 Aug; 24(5):431-9. PubMed ID: 23722649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography in unprotected left main coronary artery stenting.
    Parodi G; Maehara A; Giuliani G; Kubo T; Mintz GS; Migliorini A; Valenti R; Carrabba N; Antoniucci D
    EuroIntervention; 2010 May; 6(1):94-9. PubMed ID: 20542803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.